Login | Register

Brain cancer treatment may lie in reactivating immune cells

When they examined tumor samples of glioblastoma, the deadliest form of brain cancer, researchers in Canada discovered they contained deactivated forms of specialized immune cells that normally fight tumor-generating cells. When they tested a drug that reactivates these immune cells in diseased mice, the animals lived two to three times longer.

Leave a Reply

Your email address will not be published. Required fields are marked *